Clinical Trials on Hepatocellular Cancer

Total 53869 results

Innovent Biologics (Suzhou) Co. Ltd.

Active, not recruiting

Efficacy and Safety of IBI310 Combined With Sintilimab in Patients With Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

China
Varian Medical Systems

Completed

STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma

Localized Hepatocellular Carcinoma

China
University Hospital, Brest

Unknown

ATEZOLIZUMAB - BEVACIZUMAB in the Treatment Hepatocellular Carcinoma Inoperable or (HEPATOFIT)

Advanced Hepatocellular Carcinoma
Zai Lab (Shanghai) Co., Ltd.

Completed

A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC

Hepatocellular Carcinoma (HCC)

China
The First Affiliated Hospital with Nanjing Medical...

Unknown

Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma

China
Delcath Systems Inc.

Withdrawn

Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC

Hepatocellular Carcinoma (HCC)

United States
University of Alabama at Birmingham

Completed

A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma (RAD 0902)

Hepatocellular Carcinoma (HCC)

United States
Eastern Hepatobiliary Surgery Hospital

Completed

Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma

Unresectable Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital

Unknown

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma (TACE)

Advanced Hepatocellular Carcinoma

China
Ain Shams University

Completed

Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)
Abby Siegel
Lotte & John Hecht Memorial Foundation

Completed

Siliphos in Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

United States
Guangxi Medical University

Unknown

A Study of DC-CIK to Treat Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

China
CureTech Ltd
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma

Primary Hepatocellular Carcinoma

Israel
Guangxi Medical University

Unknown

Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications (RDSA)

HepatoCellular Carcinoma

China
Sun Yat-sen University

Unknown

The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.

HepatoCellular Carcinoma

China
Taichung Veterans General Hospital

Completed

The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer

Hepatocellular Carcinoma.

Taiwan
Sun Yat-sen University
First People's Hospital of Foshan; Guangzhou No.12 People's Hospital

Completed

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

HepatoCellular Carcinoma

China
Center Eugene Marquis
Rennes University Hospital

Completed

188RE-SSS Lipiodol to Treat HepatoCellular Carcinomas (LIP-RE-I)

Hepatocellular Carcinomas

France
Sun Yat-sen University
Guangzhou No.12 People's Hospital; Kaiping Central Hospital

Unknown

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

HepatoCellular Carcinoma

China
Ain Shams University

Completed

Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients

HepatoCellular Carcinoma
Guangxi Medical University

Unknown

Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma

HepatoCellular Carcinoma

China
ShenFeng
Sun Yat-sen University; Shanghai Zhongshan Hospital; First Affiliated Hospital... and other collaborators

Completed

the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma (Rg3)

Stage I Hepatocellular Carcinoma | Stage II Hepatocellular Carcinoma

China
Abbott

Terminated

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Liver Diseases | Digestive System Diseases | Neoplasms | Neoplasms by Histologic Type | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Carcinoma, Hepatocellular | Liver Neoplasms | Hepatocellular Carcinoma Non-resectable | Hepatocellular Carcinoma...

United States, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Czech Republic, Denmark, Egypt, France, Germany, Greece, Hong Kong, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Norway, Puerto... and more
BioInvent International AB
Merck Sharp & Dohme LLC

Recruiting

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

Hepatocellular Carcinoma | Non Small Cell Lung Cancer | Solid Tumors

Spain, Denmark, Poland, Sweden
Sun Yat-sen University

Recruiting

Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer | Recurrent Tumor | Microwave Ablation | Lenvatinib

China
Jennerex Biotherapeutics

Completed

A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (TRAVERSE)

HCC | Hepatocellular Carcinoma | Liver Cancer

Korea, Republic of, United States, Hong Kong, Canada, Germany, France, Taiwan
National Cancer Institute (NCI)

Not yet recruiting

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Metastatic Melanoma | Locally Advanced Melanoma | Metastatic Alveolar Soft Part Sarcoma | Metastatic Non Small Cell Lung Cancer | Metastatic Hepatocellular Carcinoma | Locally Advanced Hepatocellular Carcinoma | Metastatic Small Cell Lung Cancer | Locally Advanced Non Small Cell Lung Cancer | Locally... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

Cholangiocarcinoma | Adult Hepatocellular Carcinoma | Resectable Hepatocellular Carcinoma | Benign Liver Tumor | Metastases to Liver

United States
National Cancer Institute (NCI)

Withdrawn

Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction

Metastatic Malignant Solid Neoplasm | Unresectable Solid Neoplasm | Stage IIIB Hepatocellular Carcinoma AJCC v7 | Stage IIIC Hepatocellular Carcinoma AJCC v7 | Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma | Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma | Stage IV Hepatocellular Carcinoma AJCC... and other conditions

United States
New Mexico Cancer Care Alliance

Terminated

Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers (Gem-ox)

Hepatocellular Carcinoma | Bile Duct Cancer | Gallbladder Cancer | Cholangiocellular Carcinoma | Extrahepatic Bile Duct Cancer | Cholangiocarcinoma of the Extrahepatic Bile Duct | Periampullary Adenocarcinoma

United States
M.D. Anderson Cancer Center

Recruiting

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Malignant Solid Neoplasm | Metastatic Renal Cell Carcinoma | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage... and other conditions

United States
National Taiwan University Hospital

Unknown

PLA for HCC and Esophageal ca Serum

Hepatocellular Carcinoma | Esophageal Cancer

Taiwan
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer. (FASTRAK)

Hepatocellular Carcinoma | Cirrhosis | Liver Cancer | Chronic Liver Disease

France
Epigenomics, Inc
Innovis LLC

Completed

HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Cirrhosis, Liver | Liver Cancer | Hepatic Cirrhosis

United States
Massachusetts General Hospital
National Cancer Institute (NCI); Dana-Farber Cancer Institute; Brigham and Women...

Completed

Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases

Cholangiocarcinoma | Hepatocellular Cancer | Hepatic Metastases
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC

Hepatocellular Carcinoma Non-resectable

China
Tianjin Medical University Cancer Institute and...

Recruiting

Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.

Hepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectable

China
Chang Gung Memorial Hospital

Recruiting

Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma (ProtonAB)

Hepatocellular Carcinoma Non-resectable

Taiwan
Second Affiliated Hospital of Guangzhou Medical...
First People's Hospital of Foshan; Affiliated Cancer Hospital & Institute of... and other collaborators

Recruiting

Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC

Hepatocellular Carcinoma Non-resectable

China
Terumo Europe N.V.

Recruiting

BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC) (BIOPEARL-ONE)

Hepatocellular Carcinoma Non-resectable

Belgium, Germany, Italy
Wan-Guang Zhang

Recruiting

A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC (CCGLC-010)

Macrotrabecular Massive Hepatocellular Carcinoma

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

DEB-TACE vs. cTACE as Conversion Therapy for Unresectable Large HCC

Hepatocellular Carcinoma Non-resectable

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma (HCC)

China
Sohag University

Completed

ALBI and PALBI Scores and HCC Prognosis

Hepatocellular Carcinoma (HCC) Prognosis

Egypt
UMC Utrecht
Erasmus Medical Center; Dutch Cancer Society; Quirem Medical B.V.

Completed

HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectable

Netherlands
Jiangsu HengRui Medicine Co., Ltd.

Terminated

A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma (HCC)

China
Abramson Cancer Center of the University of Pennsylvania

Completed

Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)

ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

United States
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma (HCC)

China
Second Affiliated Hospital of Guangzhou Medical...

Active, not recruiting

TACE Combined With Sintilimab and Bevacizumab for Unresectable HCC

Hepatocellular Carcinoma Non-resectable

China
Zhejiang Cancer Hospital
First Affiliated Hospital of Zhejiang University; Second Affiliated Hospital... and other collaborators

Enrolling by invitation

Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC

Hepatocellular Carcinoma Stage IIIa

China

Clinical Trials on Hepatocellular Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations